Literature DB >> 21722748

Smart medication through combination of synthetic biology and cell microencapsulation.

Simon Ausländer1, Markus Wieland, Martin Fussenegger.   

Abstract

Recent advances in the field of synthetic biology have led to the design of a new generation of complex, man-made biological networks that operate inside living cells in a desired manner. Key elements of these systems are often controllable genetic switches that are capable of processing therapeutic signals by sensing and responding to the environment. For biomedical applications, however, it is necessary to seal these engineered cells in order to protect them from the host immune system and enable straightforward removal after completion of the therapy. A promising and successful approach is the microencapsulation of defined cells into a semi-permeable and biocompatible microcapsule. Shielding from the external environment still allows exchange to occur on a molecular basis. Thus, the powerful combination of synthetic biology and microencapsulation has been opening the door to novel and innovative cell-based biomedical applications, such as smart implantable drug delivery systems. This review highlights recent developments in the overlap of these two areas, thereby presenting promising developments and perspectives for future treatment strategies.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21722748     DOI: 10.1016/j.ymben.2011.06.003

Source DB:  PubMed          Journal:  Metab Eng        ISSN: 1096-7176            Impact factor:   9.783


  16 in total

1.  A Synthetic-Biology-Inspired Therapeutic Strategy for Targeting and Treating Hepatogenous Diabetes.

Authors:  Shuai Xue; Jianli Yin; Jiawei Shao; Yuanhuan Yu; Linfeng Yang; Yidan Wang; Mingqi Xie; Martin Fussenegger; Haifeng Ye
Journal:  Mol Ther       Date:  2017-02-01       Impact factor: 11.454

2.  Designed cell consortia as fragrance-programmable analog-to-digital converters.

Authors:  Marius Müller; Simon Ausländer; Andrea Spinnler; David Ausländer; Julian Sikorski; Marc Folcher; Martin Fussenegger
Journal:  Nat Chem Biol       Date:  2017-01-16       Impact factor: 15.040

3.  A Synthetic Mammalian Therapeutic Gene Circuit for Sensing and Suppressing Inflammation.

Authors:  Anže Smole; Duško Lainšček; Urban Bezeljak; Simon Horvat; Roman Jerala
Journal:  Mol Ther       Date:  2017-01-04       Impact factor: 11.454

4.  Bottom-up approaches in synthetic biology and biomaterials for tissue engineering applications.

Authors:  Mitchell S Weisenberger; Tara L Deans
Journal:  J Ind Microbiol Biotechnol       Date:  2018-03-19       Impact factor: 3.346

Review 5.  Engineering Gene Circuits for Mammalian Cell-Based Applications.

Authors:  Simon Ausländer; Martin Fussenegger
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-07-01       Impact factor: 10.005

6.  Reward-based hypertension control by a synthetic brain-dopamine interface.

Authors:  Katrin Rössger; Ghislaine Charpin-El Hamri; Martin Fussenegger
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-14       Impact factor: 11.205

Review 7.  Functionalized nanostructures with application in regenerative medicine.

Authors:  Macarena Perán; María A García; Elena López-Ruiz; Milán Bustamante; Gema Jiménez; Roberto Madeddu; Juan A Marchal
Journal:  Int J Mol Sci       Date:  2012-03-22       Impact factor: 6.208

8.  Cosmetics-triggered percutaneous remote control of transgene expression in mice.

Authors:  Hui Wang; Haifeng Ye; Mingqi Xie; Marie Daoud El-Baba; Martin Fussenegger
Journal:  Nucleic Acids Res       Date:  2015-05-05       Impact factor: 16.971

9.  Theranostic implications of nanotechnology in multiple sclerosis: a future perspective.

Authors:  Ajay Vikram Singh; Manish Khare; W N Gade; Paolo Zamboni
Journal:  Autoimmune Dis       Date:  2012-12-30

Review 10.  Biomedically relevant circuit-design strategies in mammalian synthetic biology.

Authors:  William Bacchus; Dominique Aubel; Martin Fussenegger
Journal:  Mol Syst Biol       Date:  2013       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.